Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05396196 · ClinicalTrials.gov registry record · NA

An Analysis of Kinesio® Tape With Manual Fascial Glide Application on Trigger Points in The Iliotibial Band

A NA study of Myofascial Trigger Point Pain, sponsored by North Dakota State University.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05396196: Completed NA study of Myofascial Trigger Point Pain, sponsored by North Dakota State University.

NCT05396196 is a NA study of Myofascial Trigger Point Pain that has completed, run by North Dakota State University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05396196, a NA study of Myofascial Trigger Point Pain, has completed, sponsored by North Dakota State University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Up to 15 participants between the ages of 18-55 will report for two research sessions. Prior to arrival, minimum requirements for being recreationally active or a recreational runner will be confirmed via email using the Pre-Participation Screening form. The first session will require one hour, while the second will require 30 minutes. Maximum amount of time expected is one and a half hours, over two sessions in 48 hours. The 1st and 2nd sessions will be separated by 48 hours. Upon arrival for session 1, informed consent will be obtained along with the following demographic information: age, sex, height, weight, dominant leg, and activity. Participants will then be assessed for trigger points in their dominant side iliotibial band via palpation. Diagnostic criteria for trigger point will be modeled after Travell and Simons: taut band and pain upon palpation. One to four trigger points will be marked on the subject's skin with marker or pen. Pain pressure threshold will be obtained via algometer, using the terminology "Tell me the first moment you experience pain by verbalizing 'now'. Then, three pain pressure threshold readings will be taken per trigger point and then averaged by the researcher. Following, a Visual Analogue Scale for pain will be assessed by asking the question 'On average, on a scale from 0-10 how painful was the pressure?' Kinesiology tape will then be applied to the identified trigger points using the Manual Fascial Glide. The Manual Fascial Glide will be applied with one 'I' strip horizontal to each trigger point. The tape will be anchored adjacent to the marked trigger point, a gentle pressure will be placed on the anchor while applying a lateral glide of the superficial tissue, and adhering the tape in the opposite direction at 30% tension. Pain pressure threshold will be obtained again with the same protocols 10 minutes after the tape is applied. The participant will be asked to wear the tape for 48 hours. Upon arrival for session 2, the appl

Interventions

  • DEVICE Kinesio® Tape

Study Locations (1)

North Dakota

  • North Dakota State University - Fargo

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-05-25
Est. Completion 2021-05-27
Phase NA
North Dakota State University

16 total trials

What the finished NCT05396196 record still lists

NCT05396196 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Myofascial Trigger Point Pain appearing as the primary indexed condition, and to 1 intervention - of which Kinesio® Tape is the first listed.

NCT05396196 reports a single indexed study location in North Dakota.

Frequently Asked Questions

What is clinical trial NCT05396196 about?

NCT05396196 is a clinical study titled "An Analysis of Kinesio® Tape With Manual Fascial Glide Application on Trigger Points in The Iliotibial Band". Up to 15 participants between the ages of 18-55 will report for two research sessions. Prior to arrival, minimum requirements for being recreationally active or a recreational runner will be confirmed via email using the Pre-Participation Screening form. The first session will require one hour, whil...

What is the current status of trial NCT05396196?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-05-25. Estimated completion is 2021-05-27.

What conditions does trial NCT05396196 study?

This clinical trial studies the following conditions: Myofascial Trigger Point Pain.

What interventions are being tested in trial NCT05396196?

The interventions under investigation include: Kinesio® Tape (DEVICE).

Who is sponsoring clinical trial NCT05396196?

This trial is sponsored by North Dakota State University, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05396196 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myofascial Trigger Point Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05396196's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05396196, the US trial registry maintained by the National Library of Medicine. NCT05396196 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.